OnTheIssuesLogo

Sherrod Brown on Drugs

Democratic Sr Senator; previously Representative (OH-13)

 


Supports banking access for those in the marijuana industry

Source: NORML Politician Info on 2024 Ohio Senate race , Aug 8, 2024

FEND Off Fentanyl Act: stop flow from China & Mexico

This Committee heard about the human toll that illicit fentanyl takes on our families, our friends, our neighbors. The witnesses stressed the need to come together [to take] action to stop the flow of illicit fentanyl from China and Mexico.

Last year, we included the FEND Off Fentanyl Act in the annual defense authorization bill. But this hasn't become law yet, because of politicians in the House playing politics. The FEND Off Fentanyl Act was not the only Committee priority that the House blocked.

Source: Senate press release on 2024 Ohio Senate race , Jan 18, 2024

Supports medical legalization; opposes federal intervention

Q: Legalize or decriminalize marijuana?

Sherrod Brown (D): Supports medical legalization. Wants to study how legalizing recreational works elsewhere before legalizing in Ohio. Opposes federal intervention.

Jim Renacci (R): Opposes recreational legalization. Watch how medical implementation goes. Voted against protecting states from federal intervention.

Source: 2018 CampusElect.org Issue Guide on Ohio Senate race , Oct 9, 2018

Rated Zero by NORML, indicating a mixed record on drug reform.

Brown scores Zero by the NORML on drug reform

OnTheIssues.org interprets the 2006 NORML scores as follows:

About NORML (from their website, www.norml.org):

National Organization for the Reform of Marijuana Law`s mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called `decriminalization.`

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as `legalization.`

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Source: NORML website 06n-NORML on Dec 31, 2006

Rated D by NORML, indicating a "hard-on-drugs" stance.

Brown scores D by the NORML on drug reform

OnTheIssues.org interprets the 2016 NORML scores as follows:

About NORML (from their website, www.norml.org):

National Organization for the Reform of Marijuana Law`s mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called `decriminalization.`

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as `legalization.`

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Source: NORML website 16_NORML on Nov 8, 2016

Criminalize imports of opioid precursors.

Brown signed criminalizing imports of opioid precursors

Excerpts from Letter from 17 Senators to the President of the European Commission We write to request designating NPP and ANPP, which are precursor chemicals of the synthetic opioid fentanyl, as Table I substances under the 1988 UN Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. NPP and ANPP are [legal under EU law but] already controlled in the U.S. under the Controlled Substances Act. However, without collective international action it will be difficult to control NPP and ANPP, and will frustrate efforts to curb manufacturing and trafficking of illicit fentanyl.

Opposing argument: (ACLU, `Against Drug Prohibition`): People in almost all cultures, in every era, have used psychoactive drugs. A `drug free America` is not a realistic goal, and by criminally banning psychoactive drugs the government has ceded control of potentially dangerous substances to criminals. Instead of trying to stamp out drug use, our government should focus on reducing drug abuse and prohibition-generated crime. This requires a fundamental change in public policy: repeal of criminal prohibition and the creation of a reasonable regulatory system.

Opposing argument: (Cato Institute, `Do Restrictions Reduce Opioid Poisonings?`, by Jeffrey Miron): Prescription Drug Monitoring Programs (PDMPs), which record a patient`s opioid prescribing history, when required as `must access,` PDMPs significantly reduce misuse in Medicare Part D. But there is no statistically significant effect on opioid poisoning incidents. How is this possible? The simplest explanation is that, despite all the hype, prescription opioids are not that dangerous, even in heavy doses, when used under medical supervision. Instead, most poisonings reflect use of diverted prescription opioids, or black market opioids, which may be adulterated. Under this interpretation, restrictions on opioid prescribing might even increase opioid poisonings.

Source: Letter on Fentanyl 17LTR-NPP on Feb 17, 2017

Other candidates on Drugs: Sherrod Brown on other issues:
OH Gubernatorial:
Amy Acton
Jim Renacci
John Cranley
Jon Husted
Nan Whaley
OH Senatorial:
Bernie Moreno
Frank LaRose
Jane Timken
JD Vance
Jon Husted
Josh Mandel
Matt Dolan
Mike Gibbons
Morgan Harper
Ted Strickland
Tim Ryan

OH politicians
OH Archives
Senate races 2026:
AK: Dan Sullivan(R,incumbent)
vs.Andy Barr(R)
vs.Mary Peltola(D)
AL: Tommy Tuberville(R,retiring)
vs.Barry Moore(R)
vs.Steve Marshall(R)
AR: Tom Cotton(R,incumbent)
vs.Dan Whitfield(I,withdrew)
vs.Ethan Dunbar(D)
CO: John Hickenlooper(D,incumbent)
vs.Janak Joshi(R)
vs.Julie Gonzales(D)
vs.Mark Baisley(R)
DE: Chris Coons(D,incumbent)
vs.Mike Katz(I)
FL: Ashley Moody(R,appointee)
vs.Alan Grayson(D)
vs.Angie Nixon(D)
GA: Jon Ossoff(D,incumbent)
vs.Buddy Carter(R)
vs.Mike Collins(R)
vs.John F. King(R,withdrew)
IA: Joni Ernst(R,retiring)
vs.Ashley Hinson(R)
vs.Bob Krause(D)
vs.Jim Carlin(R)
vs.J.D. Scholten(D,withdrew)
ID: Jim Risch(R,incumbent)
vs.David Roth(D)
vs.Todd Achilles(I)
IL: Richard Durbin(D,retiring)
vs.Juliana Stratton(D)
vs.Raja Krishnamoorthi(D)
vs.Robin Kelly(D)
KS: Roger Marshall(R,incumbent)
vs.Patrick Schmidt(D)
KY: Mitch McConnell(R,retiring)
vs.Charles Booker(D)
vs.Daniel Cameron(R)
vs.Pamela Stevenson(D)
LA: Bill Cassidy(R,incumbent)
vs.John Fleming(R)
vs.Julia Letlow(R)
MA: Ed Markey(D,incumbent)
vs.Seth Moulton(D)
vs.John Deaton(R)
ME: Susan Collins(R,incumbent)
vs.Janet Mills(D)
MI: Gary Peters(D,retiring)
vs.Haley Stevens(D)
vs.Joe Tate(R,withdrew)
vs.Mallory McMorrow(D)
vs.Mike Rogers(R)

MN: Tina Smith(D,retiring)
vs.Angie Craig(D)
vs.David Hann(R)
vs.Peggy Flanagan(D)
vs.Royce White(R)
MS: Cindy Hyde-Smith(R,incumbent)
vs.Ty Pinkins(D)
MT: Steve Daines(R,incumbent)
vs.Reilly Neill(D)
NC: Thom Tillis(R,retiring)
vs.Michael Whatley(R)
vs.Roy Cooper(D)
NE: Peter Ricketts(R,incumbent)
vs.Dan Osborn(I)
NH: Jeanne Shaheen(D,retiring)
vs.Chris Pappas(D)
vs.John Sununu(R)
vs.Scott Brown(R)
NJ: Cory Booker(D,incumbent)
vs.Justin Murphy(R)
NM: Ben Ray Lujan(D,incumbent)
vs.Matt Dodson(D)
OH: Jon Husted(R,appointee)
vs.Sherrod Brown(D)
OK: Markwayne Mullin(R,incumbent)
vs.Troy Green(D)
OR: Jeff Merkley(D,incumbent)
vs.Jo Rae Perkins(R)
RI: Jack Reed(D,incumbent)
vs.Connor Burbridge(D)
SC: Lindsey Graham(R,incumbent)
vs.Catherine Fleming Bruce(D)
vs.Paul Dans(R)
SD: Mike Rounds(R,incumbent)
vs.Brian Bengs(I)
TN: Bill Hagerty(R,incumbent)
vs.Diana Onyejiaka(D)
TX: John Cornyn(R,incumbent)
vs.Ken Paxton(R)
vs.Wesley Hunt(R)
vs.James Talarico(D)
vs.Jasmine Crockett(D)
VA: Mark Warner(D,incumbent)
vs.David Williams(R)
WV: Shelley Moore Capito(R,incumbent)
vs.Jeff Kessler(D)
vs.Tom Willis(R)
WY: Cynthia Lummis(R,retiring)
vs.Harriet Hageman(R)
vs.Reid Rasner(R)
Abortion
Budget/Economy
Civil Rights
Corporations
Crime
Drugs
Education
Energy/Oil
Environment
Families
Foreign Policy
Free Trade
Govt. Reform
Gun Control
Health Care
Homeland Security
Immigration
Jobs
Principles
Social Security
Tax Reform
Technology
War/Peace
Welfare

Other Senators
Congressional Votes (analysis)
Congressional Ratings
Affiliations
Policy Reports




Page last updated: Feb 15, 2026; copyright 1999-2022 Jesse Gordon and OnTheIssues.org